查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1809778

CRP 测量设备市场按类型、检测技术、样本类型、便携性、适应症区域、最终用户和销售管道- 全球预测，2025-2030 年

C-reactive Protein Analyzer Market by Type, Detection Technology, Sample Type, Portability, Application Area, End User, Sales Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

CRP测量设备市场预计到2024年将达到20.6亿美元，到2025年将达到21.7亿美元，到2030年将达到28.5亿美元，复合年增长率为5.52%。

主要市场统计数据
基准年2024年 20.6亿美元
预计2025年 21.7亿美元
预测年份 2030 28.5亿美元
复合年增长率（%） 5.52%

CRP分析的创新和准确性为推动诊断和患者照护迈向新高度奠定了基础

过去十年，C反应蛋白已成为评估全身性发炎、指南心臟病学、风湿病学、感染疾病管理等领域临床决策的关键生物标记。随着全球慢性病盛行率持续上升，医疗保健提供者越来越依赖准确的C反应蛋白测量来制定个人化治疗方法并追踪治疗效果。对强大诊断工具日益增长的需求引发了分析设备领域的创新，无论是老牌公司还是灵活的新兴企业都在致力于提升侦测效能和工作流程整合。

开创性的技术进步和市场动态正在改变全球 CRP 分析格局

检测技术的最新突破正在重新定义C反应蛋白检测的分析能力，使其远远超越传统的免疫比浊法。酵素结合免疫吸附检测法与先进的萤光偏振和免疫比浊法相结合，提高了灵敏度和特异性，使临床医生能够检测到发炎特征的细微变化。同时，晶粒平台也得到了改进，以缩短週转时间并支持集中实验室的更高通量。

全面评估2025年美国关税对CRP分析仪供应链与创新的影响

2025年美国关税的实施将影响CRP分析仪及相关耗材的经济效益，并重塑整个供应链的筹资策略。随着进口零件和试剂关税的提高，製造商和经销商可能面临更高的投入成本，这些成本可能会转嫁给最终用户，或透过压缩利润率来消化。预计这些政策变化将促使企业重新评估全球采购依赖关係和合约条款。

按类型、检测技术、样品类型、便携性、应用领域、最终用户和销售管道分類的市场细分洞察

按设备类型划分市场时，高通量实验室自动化系统（由化学和免疫检测分析仪组成）与用于床边快速诊断的分散式照护现场平台之间存在明显的区分。这种差异反映了基本的临床用例：集中式分析仪优化了高通量检测，而照护现场设备则适用于门诊和急诊环境中的紧急医疗使用案例。

了解美洲、欧洲、中东和非洲地区以及亚太地区的区域动态，以指导战略市场扩张和区域方法

在美洲，美国和加拿大凭藉强大的医疗基础设施、优惠的报销制度和大量的研发投入处于领先地位。这些市场的临床实验室正主导采用高通量化学和免疫检测分析仪，并利用先进的自动化技术来满足日益增长的检测需求。同时，拉丁美洲的新兴市场也越来越多地采用即时诊断 (POC) 解决方案，以扩大偏远和服务不足地区的快速诊断服务覆盖范围。

产业领导者的策略性倡议塑造了 CRP 分析的未来；强调伙伴关係和竞争优势

CRP分析领域的主要企业正在采取多样化的策略来保持竞争优势。许多现有的仪器製造商越来越注重端到端解决方案，将分析仪硬体与专有的检测试剂套件和数位健康平台相结合，以提高客户忠诚度并实现远端效能监控。这种整体方法增强了服务产品，并透过销售耗材创造了经常性收益来源。

策略行动计划和最佳实践，以利用新兴趋势并加强您在蛋白质测定创新方面的市场地位

为了应对不断变化的市场格局并抓住成长机会，产业领导者应优先考虑供应链多元化，并探索近岸和本地製造合作，以减轻关税的影响，并确保关键试剂和零件的可靠供应。与物流合作伙伴的早期合作将进一步增强配送弹性，并最大限度地减少日常维护和耗材补给造成的中断。

概述一个严格的混合研究框架，该框架整合了主要访谈、二手资料分析和三角测量，以获得公正的市场情报

支撑本分析的研究框架结合了严谨的一级研究和二级研究，以确保提供全面且公正的市场资讯。二级研究系统性地回顾了同行评审的科学文献、监管备案文件、临床指南和公开的企业资料，以了解技术趋势和竞争格局。本次案头研究为分析方法、仪器规格和历史演变提供了基础见解。

整合关键发现与策略要务，掌握 CRP 分析市场格局中的未来机会

如本执行摘要所示，CRP 检测市场正在经历快速转型，这得益于检测技术的进步、自动化能力的提升以及对分散式检查解决方案日益增长的需求。详细的細項分析揭示了仪器类型、检测技术、样品基质和应用需求之间微妙的相互作用。此外，区域动态凸显了根据当地基础设施、法律规范和经济状况制定客製化策略的必要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 医院实验室对自动化 CRP 测量设备的需求不断增加
  • CRP测量设备中人工智慧和机器学习的集成
  • 严格的监管核准推动CRP测量设备的创新和安全
  • CRP 仪在慢性病管理和病患监测计画的应用日益广泛
  • 奈米技术的进步显着提高了 CRP 测量设备的灵敏度和准确性
  • 生物技术公司和医疗保健提供者合作改进CRP测量设备
  • 开发结合C反应蛋白测试的多参数分析仪
  • CRP测量设备的临床应用不仅限于心血管疾病
  • 远端医疗中可携式CRP 测量设备的采用日益增多
  • 用于快速诊断的照护现场CRP 测量设备的出现

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章 CRP 测量设备市场（按类型）

  • 实验室自动化系统
    • 化学分析仪
    • 免疫检测分析仪
  • 照护现场

9. CRP测量设备市场（依检测技术）

  • 酵素免疫检测（ELISA）
  • 萤光偏振（FP）
  • 免疫比浊法
  • 免疫浊度测量

第 10 章。按样本类型分類的 CRP 测量设备市场

  • 血
  • 电浆
  • 血清

第 11 章 CRP 测量设备市场（以便携性）

  • 固定的
  • 可携式的

第12章 CRP测量设备市场（依应用）

  • 自体免疫疾病管理
  • 心血管疾病风险评估
  • 消化系统疾病管理
  • 感染监测
    • 细菌感染检测
    • 病毒感染检测
  • 发炎监测

第十三章 CRP 测量设备市场（依最终用户）

  • 诊断实验室
  • 医院和诊所
  • 研究所

第14章 CRP测量设备市场按销售管道

  • 线下销售
    • 直销
    • 经销商
  • 网上销售
    • 品牌网站
    • 电商平台

第 15 章美洲 CRP 电錶市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第16章欧洲、中东和非洲CRP仪表市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

第十七章亚太CRP仪表市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十八章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abaxis, Inc. by Zoetis Inc.
    • Abbott Laboratories
    • biosurfit SA
    • Boditech Med Inc.
    • Danaher Corporation
    • DIRUI INDUSTRIAL CO., LTD.
    • DxGen Corp.
    • F. Hoffmann-La Roche AG
    • Getein Biotech, Inc.
    • Goldsite Diagnostics Inc.
    • Hangzhou Realy Tech Co., Ltd.
    • HORIBA, Ltd.
    • Neomedica
    • Nova Biomedical
    • SD Biosensor, INC.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Shenzhen New Industry Biomedical Engineering Co., Ltd.
    • Siemens Healthineers AG

第十九章 研究人工智慧

第20章 研究统计

第21章 研究联络人

第22章 研究报导

第23章 附录

Product Code: MRR-2B5802CFEB40

The C-reactive Protein Analyzer Market was valued at USD 2.06 billion in 2024 and is projected to grow to USD 2.17 billion in 2025, with a CAGR of 5.52%, reaching USD 2.85 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.06 billion
Estimated Year [2025] USD 2.17 billion
Forecast Year [2030] USD 2.85 billion
CAGR (%) 5.52%

Setting the Stage for Innovation and Precision in C-reactive Protein Analysis to Propel Diagnostics and Patient Care to New Heights

Over the last decade, C-reactive protein has emerged as a pivotal biomarker for assessing systemic inflammation, guiding clinical decisions across cardiology, rheumatology, and infection management. As the prevalence of chronic diseases continues to rise globally, healthcare providers increasingly rely on accurate CRP measurements to personalize treatment regimens and track therapeutic efficacy. This intensifying demand for robust diagnostic tools has catalyzed innovation within the analyzer segment, prompting both established companies and agile startups to enhance assay performance and workflow integration.

Moreover, advances in laboratory automation have improved throughput, while next-generation platforms now offer seamless digital connectivity for real-time data transfer and interoperability with electronic health records. Parallel developments in point-of-care solutions have driven miniaturization and simplified user interfaces, empowering clinicians to obtain reliable results at the bedside or in decentralized settings. These technological strides, coupled with heightened regulatory emphasis on standardization and quality control, underscore a paradigm shift toward more accessible, efficient diagnostic ecosystems.

In response to these evolving dynamics, this executive summary delves into transformative market shifts and examines the implications of forthcoming United States tariff measures for 2025. It presents a nuanced segmentation analysis, highlights regional growth trajectories, and distills competitive intelligence into actionable insights.

By combining rigorous methodological approaches with strategic foresight, this report aims to equip industry stakeholders with the clarity and confidence needed to navigate a rapidly changing landscape and seize emerging opportunities.

Revealing Pioneering Technological Advances and Market Dynamics Revolutionizing the Global C-reactive Protein Analysis Landscape

Recent breakthroughs in detection technologies have redefined the analytical capabilities of C-reactive protein assays, moving well beyond traditional immunoturbidimetric methods. The integration of enzyme-linked immunosorbent assay techniques with advanced fluorescence polarization and immunonephelometry has enhanced sensitivity and specificity, enabling clinicians to detect subtle changes in inflammatory profiles. Concurrently, immunoturbidimetric platforms have undergone refinement to deliver faster turnaround times and support higher throughput in centralized laboratories.

Furthermore, the advent of sophisticated laboratory automation systems has streamlined sample processing across chemistry and immunoassay analyzers, reducing manual intervention and minimizing the risk of human error. Artificial intelligence and machine learning algorithms now augment data interpretation, identifying patterns that inform predictive diagnostics and personalized care pathways. At the same time, point-of-care analyzers have become increasingly portable, combining robust detection technologies with user-friendly interfaces to facilitate near-patient testing in clinics and remote settings.

In addition, emerging regulatory frameworks and reimbursement models are promoting value-based care, prompting stakeholders to seek cost-effective diagnostic solutions without compromising performance. Decentralized testing approaches are gaining traction, driven by the need to expand access to rapid, accurate inflammatory marker quantification among diverse patient populations.

Consequently, these transformative shifts in both technology and market dynamics are setting the stage for a new era in C-reactive protein analysis. As the industry continues to evolve, stakeholders must remain agile, embracing innovation to meet rising clinical demands and capitalize on untapped opportunities.

Assessing the Comprehensive Effects of 2025 United States Tariff Measures on C-reactive Protein Analyzer Supply Chains and Innovation

The introduction of heightened US tariff measures in 2025 is poised to influence the economics of C-reactive protein analyzers and associated consumables, reshaping procurement strategies across the supply chain. With increased duties on imported components and reagents, manufacturers and distributors may face elevated input costs, which could be passed along to end users or absorbed through margin compression. These policy changes are expected to drive a reevaluation of global sourcing dependencies and contractual terms.

As a result, many suppliers are already exploring alternative procurement routes, including nearshoring of critical reagent production and forging strategic partnerships with local manufacturers. Such initiatives aim to mitigate exposure to fluctuating trade policies and currency volatility. Nevertheless, transition periods may introduce temporary bottlenecks, extended lead times, and logistical complexities, potentially disrupting routine maintenance schedules and service agreements for laboratory automation systems and point-of-care devices alike.

Moreover, diagnostic laboratories and healthcare institutions may need to adjust inventory management practices, embracing just-in-time delivery models and enhancing collaboration with vendors to secure reliable supply. In parallel, companies are investing in product redesigns to optimize bill of materials and reduce tariff liabilities, without compromising analytical performance or regulatory compliance.

Ultimately, while these tariff measures present immediate challenges, they also offer an impetus for supply chain resilience and innovation. By proactively diversifying sourcing strategies and streamlining manufacturing processes, stakeholders can safeguard operational continuity and sustain cost-effective access to critical diagnostic solutions.

Deriving Actionable Market Segmentation Insights Across Types Detection Technologies Portability Applications and End Users to Guide Strategy

In examining market segmentation by instrument type, a clear divergence emerges between high-throughput laboratory automation systems-comprising chemistry analyzers and immunoassay analyzers-and decentralized point-of-care platforms designed for rapid bedside diagnostics. This distinction reflects underlying clinical use cases, with centralized analyzers optimizing large-volume testing and point-of-care devices serving urgent care scenarios in outpatient clinics or emergency settings.

Transitioning to detection technology, the landscape encompasses enzyme-linked immunosorbent assay platforms renowned for sensitivity, alongside fluorescence polarization systems that offer precise quantitation. Immunonephelometry techniques continue to deliver robust bulk analysis, and refined immunoturbidimetric methods contribute to reliable throughput in diverse laboratory environments. Each technology pathway offers distinct performance trade-offs in terms of speed, resource consumption, and integration complexity.

Furthermore, the choice of sample type-whether whole blood, plasma, or serum-interacts with portability requirements, as fixed analyzers in centralized labs can accommodate a broader range of sample preparations, while portable instruments must balance fluid handling simplicity with analytical accuracy. This interplay influences procurement decisions and operational workflows across clinical settings.

Application areas span autoimmune disease management, cardiovascular risk assessment, gastrointestinal disease monitoring, and both bacterial and viral infection diagnostics, in addition to general inflammation tracking. End users range from diagnostic laboratories and hospitals to specialized research institutes. Sales channels include traditional direct and distributor networks, complemented by digital platforms such as brand websites and e-commerce channels, each presenting unique service and support dynamics.

Uncovering Distinct Regional Dynamics Across the Americas EMEA and Asia-Pacific to Guide Strategic Market Expansion and Localized Approaches

Within the Americas region, the United States and Canada maintain leadership roles driven by robust healthcare infrastructures, favorable reimbursement frameworks, and significant research and development investments. Clinical laboratories in these markets prioritize high-throughput chemistry and immunoassay analyzers, leveraging advanced automation to meet volume demands. Meanwhile, emerging markets in Latin America exhibit growing adoption of point-of-care solutions to expand access to rapid diagnostics in remote and underserved communities.

Across Europe, the Middle East, and Africa, regulatory harmonization initiatives-such as pan-European standards and regional quality control programs-are fostering consistency in assay performance and accreditation requirements. Western European nations demonstrate strong uptake of next-generation detection technologies, underpinned by well-established laboratory networks, whereas several Middle Eastern countries are channeling healthcare expenditure into point-of-care diagnostics to address acute care pressures. In Africa, market growth is propelled by partnerships with public health organizations seeking to enhance infection monitoring capabilities.

In the Asia-Pacific corridor, rapid urbanization and government-led healthcare modernization efforts are stimulating demand for both fixed and portable analyzers. Countries with high incidences of infectious and inflammatory conditions are particularly focused on deploying decentralized testing solutions to manage public health challenges efficiently. Additionally, local manufacturing initiatives and strategic alliances are strengthening supply chain resilience, while cost sensitivity encourages the development of scalable, value-based diagnostic offerings.

These regional dynamics underscore the importance of tailored strategies that align technology portfolios with local healthcare priorities, regulatory environments, and economic considerations.

Highlighting Strategic Moves Partnerships and Competitive Differentiators of Leading Industry Players Shaping the Future of C-reactive Protein Analysis

Leading companies in the C-reactive protein analyzer arena are pursuing diversified strategies to sustain competitive advantage. Many established instrument manufacturers have intensified their focus on end-to-end solutions, integrating analyzer hardware with proprietary assay kits and digital health platforms to foster customer loyalty and enable remote performance monitoring. This holistic approach enhances service offerings and creates recurring revenue streams through consumable sales.

Simultaneously, emerging players are carving out niches by advancing portable and user-friendly point-of-care systems, often incorporating cloud-based analytics and mobile connectivity. Such innovations cater to decentralized testing environments and support telehealth initiatives, thereby expanding market reach beyond traditional laboratory settings. Strategic alliances between technology disruptors and legacy firms are also on the rise, leveraging complementary strengths in assay development and manufacturing scale.

In addition, several key actors are channeling resources into research collaborations and targeted acquisitions to accelerate portfolio diversification. Joint ventures with reagent specialists and partnerships with academic institutions are facilitating the co-development of novel detection chemistries and multiplex assay capabilities. Through these endeavors, companies aim to anticipate clinical needs in areas such as cardiovascular risk stratification and autoimmune disease management.

Furthermore, regional expansion remains a priority, with multiple leaders establishing local service hubs and distribution networks to ensure timely maintenance and support. By combining global expertise with localized engagement, these organizations are positioned to deliver high-quality diagnostic solutions tailored to diverse healthcare markets.

Strategic Action Plans and Best Practices to Capitalize on Emerging Trends and Reinforce Market Position in Protein Assay Innovation

To navigate the evolving landscape and capture growth opportunities, industry leaders should prioritize supply chain diversification, exploring nearshore and local manufacturing collaborations to mitigate tariff exposure and ensure reliable access to critical reagents and components. Early engagement with logistics partners will further strengthen distribution resilience and minimize disruptions to scheduled maintenance and consumable replenishment.

Investment in platform interoperability and digital connectivity is also essential. By integrating analyzers with cloud-enabled analytics and electronic health record systems, stakeholders can offer differentiated value propositions that streamline clinical workflows and support data-driven decision-making. This focus on digital enablement will foster long-term customer loyalty and unlock new service models, including remote monitoring and predictive maintenance.

Strategic alliances with healthcare providers and research institutions should be pursued to co-create application-specific solutions, particularly in high-potential areas such as cardiovascular risk assessment and infection diagnostics. Collaborating on clinical validation studies and real-world evidence generation will accelerate market adoption and substantiate performance claims under evolving regulatory frameworks.

Furthermore, targeted regional strategies are required to address local market nuances. Tailoring product configurations, service offerings, and commercial models to align with regional healthcare priorities and reimbursement structures will optimize market penetration. Finally, continuous evaluation of emerging detection technologies and responsiveness to regulatory changes will ensure readiness to capitalize on next-generation assay innovations.

Outlining a Rigorous Mixed Research Framework Integrating Primary Interviews Secondary Data Analysis and Triangulation for Unbiased Market Intelligence

The research framework underpinning this analysis combines rigorous primary and secondary approaches to ensure comprehensive, unbiased market intelligence. Secondary research involved a systematic review of peer-reviewed scientific literature, regulatory filings, clinical guidelines, and publicly available corporate disclosures to map technological trends and competitive landscapes. This desk research provided foundational insights into assay methodologies, device specifications, and historical evolution.

Primary research entailed structured interviews with industry experts, including laboratory directors, clinical researchers, and procurement specialists, to capture real-world perspectives on technology adoption, workflow challenges, and unmet needs. In addition, targeted surveys were conducted across diagnostic laboratories and healthcare institutions to quantify adoption patterns and identify criteria influencing analyzer selection. Field visits to reference labs and point-of-care settings offered direct observation of operational dynamics and performance expectations.

Data triangulation served as a critical validation mechanism, correlating findings from multiple sources to enhance reliability. Wherever possible, quantitative modeling supplemented qualitative inputs, generating scenario analyses to highlight the potential impact of market variables such as tariff changes and regional regulatory shifts. Quality control measures, including peer reviews and consistency checks, were implemented at each research phase to uphold methodological integrity.

This structured approach ensures that conclusions and recommendations reflect a balanced, in-depth understanding of current market conditions, stakeholder priorities, and emerging trends, equipping decision-makers with actionable intelligence for strategic planning.

Synthesizing Key Findings and Strategic Imperatives to Navigate Future Opportunities in the C-reactive Protein Analysis Market Landscape

As this executive summary has illustrated, the C-reactive protein analyzer market is undergoing rapid transformation driven by advances in detection technologies, expanding automation capabilities, and the rising demand for decentralized testing solutions. Detailed segmentation analysis has revealed the nuanced interplay between instrument types, assay methodologies, sample matrices, and application requirements. Regional dynamics further emphasize the need for bespoke strategies that align with local infrastructure, regulatory frameworks, and economic contexts.

Moreover, the anticipated impact of 2025 United States tariff measures underscores the importance of supply chain agility and proactive cost management. Stakeholders must embrace diverse sourcing models and agile manufacturing practices to mitigate potential disruptions while sustaining innovation performance. Strategic collaborations, particularly in high-growth applications such as cardiovascular risk stratification and infection monitoring, will be pivotal in driving adoption and strengthening competitive positioning.

Looking ahead, success in this evolving landscape will depend on continuous investment in next-generation assay chemistries, data integration solutions, and robust service networks. Regulatory alignment and adherence to stringent quality standards will remain essential, ensuring that new platforms meet both clinical and clinical laboratory accreditation requirements.

Ultimately, industry participants that combine technological leadership with agile commercial execution and collaborative alliances will be best positioned to capitalize on emerging opportunities. By leveraging the insights presented in this report, decision-makers can chart a clear path toward sustainable growth and enhanced patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Rising demand for automated C-reactive protein analyzers in hospital laboratories
  • 5.2. Integration of AI and machine learning in C-reactive protein analyzer
  • 5.3. Impact of stringent regulatory approvals driving innovation and safety in C-reactive protein analyzer devices
  • 5.4. Increasing utilization of C-reactive protein analyzers in chronic disease management and patient monitoring programs
  • 5.5. Nanotechnology advancements significantly enhancing the sensitivity and accuracy of C-reactive protein analyzers
  • 5.6. Collaboration between biotech firms and healthcare providers to improve C-reactive protein analyzer
  • 5.7. Development of multi-parameter analyzers incorporating C-reactive protein testing
  • 5.8. Expansion of clinical applications for C-reactive protein analyzers beyond cardiovascular diseases
  • 5.9. Growing adoption of portable C-reactive protein analyzers in remote healthcare
  • 5.10. Emergence of point-of-care C-reactive protein analyzers for rapid diagnostics

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. C-reactive Protein Analyzer Market, by Type

  • 8.1. Introduction
  • 8.2. Laboratory Automation System
    • 8.2.1. Chemistry Analyzer
    • 8.2.2. Immunoassay Analyzer
  • 8.3. Point Of Care

9. C-reactive Protein Analyzer Market, by Detection Technology

  • 9.1. Introduction
  • 9.2. Enzyme-Linked Immunosorbent Assay
  • 9.3. Fluorescence Polarization
  • 9.4. Immunonephelometry
  • 9.5. Immunoturbidimetric

10. C-reactive Protein Analyzer Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood
  • 10.3. Plasma
  • 10.4. Serum

11. C-reactive Protein Analyzer Market, by Portability

  • 11.1. Introduction
  • 11.2. Fixed
  • 11.3. Portable

12. C-reactive Protein Analyzer Market, by Application Area

  • 12.1. Introduction
  • 12.2. Autoimmune Disease Management
  • 12.3. Cardiovascular Disease Risk Assessment
  • 12.4. Gastrointestinal Disease Management
  • 12.5. Infection Monitoring
    • 12.5.1. Bacterial Infection Detection
    • 12.5.2. Viral Infection Detection
  • 12.6. Inflammation Monitoring

13. C-reactive Protein Analyzer Market, by End User

  • 13.1. Introduction
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals & Clinics
  • 13.4. Research Institutes

14. C-reactive Protein Analyzer Market, by Sales Channel

  • 14.1. Introduction
  • 14.2. Offline Sales
    • 14.2.1. Direct Sales
    • 14.2.2. Distributors
  • 14.3. Online Sales
    • 14.3.1. Brand Websites
    • 14.3.2. E-commerce Platforms

15. Americas C-reactive Protein Analyzer Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa C-reactive Protein Analyzer Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific C-reactive Protein Analyzer Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Abaxis, Inc. by Zoetis Inc.
    • 18.3.2. Abbott Laboratories
    • 18.3.3. biosurfit SA
    • 18.3.4. Boditech Med Inc.
    • 18.3.5. Danaher Corporation
    • 18.3.6. DIRUI INDUSTRIAL CO., LTD.
    • 18.3.7. DxGen Corp.
    • 18.3.8. F. Hoffmann-La Roche AG
    • 18.3.9. Getein Biotech, Inc.
    • 18.3.10. Goldsite Diagnostics Inc.
    • 18.3.11. Hangzhou Realy Tech Co., Ltd.
    • 18.3.12. HORIBA, Ltd.
    • 18.3.13. Neomedica
    • 18.3.14. Nova Biomedical
    • 18.3.15. SD Biosensor, INC.
    • 18.3.16. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 18.3.17. Shenzhen New Industry Biomedical Engineering Co., Ltd.
    • 18.3.18. Siemens Healthineers AG

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. C-REACTIVE PROTEIN ANALYZER MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. C-REACTIVE PROTEIN ANALYZER MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. C-REACTIVE PROTEIN ANALYZER MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. C-REACTIVE PROTEIN ANALYZER MARKET: RESEARCHAI
  • FIGURE 30. C-REACTIVE PROTEIN ANALYZER MARKET: RESEARCHSTATISTICS
  • FIGURE 31. C-REACTIVE PROTEIN ANALYZER MARKET: RESEARCHCONTACTS
  • FIGURE 32. C-REACTIVE PROTEIN ANALYZER MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. C-REACTIVE PROTEIN ANALYZER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY CHEMISTRY ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY CHEMISTRY ANALYZER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY IMMUNOASSAY ANALYZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY IMMUNOASSAY ANALYZER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY FLUORESCENCE POLARIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY FLUORESCENCE POLARIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY IMMUNONEPHELOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY IMMUNONEPHELOMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY IMMUNOTURBIDIMETRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY IMMUNOTURBIDIMETRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY FIXED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY AUTOIMMUNE DISEASE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY AUTOIMMUNE DISEASE MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY CARDIOVASCULAR DISEASE RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY CARDIOVASCULAR DISEASE RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY GASTROINTESTINAL DISEASE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY GASTROINTESTINAL DISEASE MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY BACTERIAL INFECTION DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY BACTERIAL INFECTION DETECTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY VIRAL INFECTION DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY VIRAL INFECTION DETECTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFLAMMATION MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFLAMMATION MONITORING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 212. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 223. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 224. ARGENTINA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 263. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 265. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 271. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 275. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 277. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 279. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 280. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 283. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITORING, 2025-2030 (USD MILLION)
  • TABLE 285. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 287. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 289. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 290. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY OFFLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 291. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 292. GERMANY C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
  • TABLE 293. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY LABORATORY AUTOMATION SYSTEM, 2025-2030 (USD MILLION)
  • TABLE 297. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 299. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 301. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 302. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY PORTABILITY, 2025-2030 (USD MILLION)
  • TABLE 303. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
  • TABLE 304. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
  • TABLE 305. FRANCE C-REACTIVE PROTEIN ANALYZER MARKET SIZE, BY INFECTION MONITO